Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Parametric or non-parametric comparisons were used as dictated by data distribution
Giblin et al., 'Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials', Diabetes Obes
ASL is funded by the National Institutes of Health grant 5T32DK007135-46
Type 2 Diabetes Focus Tirzepatide Tirzepatide has 5 SURPASS T2D trials, FDA approval for diabetes (Mounjaro), and demonstrated superiority over semaglutide in SURPASS-2
US$ 20.25
US$ 28.29
US$ 24.93
US$ 27.90
US$ 21.94
US$ 26.00
US$ 22.98
